Kramer, Daniel Bruce
- Beth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)
From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.
FY2023 NIH rank #6,123
- Rising Star
- R01 Holder
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2013 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
NIH Funding · FY2023
Linked Award Amount
$1.4M
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#6,123
By linked amount among FY2023 PIs
Earliest Year Loaded
2013
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2023 award records by amount
NIH award records listing Kramer, Daniel Bruce as a PI. Multi-PI records show the full award amount for context.
- 5R01HL161697-02R01Contact PIProspective Investigation of Palliative and End-of-Life ExpeRiences with ICDs (PIPER-ICD) StudyBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$734.2Kaward amount
- 5R01AG068141-03R01Contact PIThe Trajectories and Clinical Experiences of ICD Therapy (TRACER-ICD) StudyBeth Israel Deaconess Medical Center · Internal Medicine (investigator's affiliation)$714.9Kaward amount
Award organization
Organizations that administered FY2023 awards listing Kramer, Daniel Bruce as a PI.
FY2023 award administered by Beth Israel Deaconess Medical Center (MA).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2013First NIH AwardBeth Israel Deaconess Medical Center
- 2015$500K Cumulative Funding
- 2015R01 Grant Holder
- 2021$1M Cumulative Funding
- 2022$2M Cumulative Funding
- 2022Entered Top 50% NationallyRanked #5472